The Cigna Group (CI)
What changed in recent filings
- Evernorth segment 79% → 84%Sep 30, 2024 → Jun 30, 2026
- Institutions — 6 new · 1 added · 3 reduced13F · as of end of 2026 Q2
What changed in recent SEC filings — factual, not a buy/sell recommendation.
Institutions holding The Cigna Group
How many of the institutions we track reported holding this stock, quarter by quarter.
2019 Q1: 3 → 2026 Q2: 11 institutions
Counts the 52 institutions we track that reported holding this stock — their full reported holdings, not just the largest positions. Not the total number of institutional holders in the US. Figures are as of quarter-end and disclosed up to 45 days later. Descriptive only — not investment advice.
Which institutions hold The Cigna Group
Institutions we track that reported holding this stock in their most recent 13F.
- Glenview Capital Management2.07% of portfolio · held as of 2019 Q1 or earlier
- Dodge & Cox1.76% of portfolio · held as of 2019 Q1 or earlier
- Bridgewater Associates0.10% of portfolio · since 2021 Q2
- Moore Capital Management0.29% of portfolio · since 2025 Q2
- Greenlight Capital0.62% of portfolio · since 2025 Q2
- Tudor Investment CorpNew this quarter0.03% of portfolio · since 2026 Q2
- Pzena Investment Management0.45% of portfolio · held as of 2026 Q2 or earlier
- GQG Partners3.03% of portfolio · held as of 2026 Q2 or earlier
- Caisse de depot (Quebec)0.28% of portfolio · held as of 2026 Q2 or earlier
- National Pension Service (Korea)0.14% of portfolio · held as of 2026 Q2 or earlier
- Capital World Investors0.04% of portfolio · held as of 2026 Q2 or earlier
Based on 13F filings — quarter-end holdings, disclosed up to 45 days later. Holding a stock is a fact we report, not a recommendation to buy or sell.
Company overview
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
What is the Biotech & Health sector?
Pharma, biotech, and medical devices. Driven by trial-result events.
The Cigna Group is classified under the Biotech & Health sector. See peers below.
CI segment revenue mix trend
Quarterly change in segment revenue share · verified from SEC filings
ETFs holding The Cigna Group
Per SEC N-PORT · 2026-06-30 · by weight · factual
CI on Stocklore
- Revenue by segment — segment weights verified from SEC filings, YoY changes, growth drivers and concentration
- Financials & earnings quality — 6 metrics (FCF conversion, ROIC, net debt, etc.) to gauge profit quality
- 13F institutional holdings — holdings and weight changes of major institutions (45-day delay)
- Sector-relative metrics — Valuation and growth compared with the Biotech & Health average
Peers · Biotech & Health
CI FAQ
What is The Cigna Group (CI)?
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense, and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 16 million US and 2 million international medical members covered as of December 2025.
What sector is The Cigna Group in?
The Cigna Group is classified under Biotech & Health. Pharma, biotech, and medical devices. Driven by trial-result events.
Where can I analyze The Cigna Group (CI) stock?
On Stocklore you can see CI's financials & earnings quality, 13F institutional holdings, and sector-relative metrics in one place. This page is for information and tools — not a buy/sell recommendation.
Data sources: SEC EDGAR (financials & filings), 13F (institutional holdings, as of quarter-end), market data. This page is for information and analysis tools — it does not recommend buying or selling any security. Investment decisions and responsibility are your own.